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The effect of 12-0-tetradecanoyl-phorbol-13-acetate 
(TPA) on cyclic adenosine 3',5'-monophosphate (cyclic 
AMP) level in adult mouse skin in response to ischemia 
was examined. The incubation of skin pieces in a 
buffered salts medium at 37°C resulted in a rapid accu-
mulation of cyclic AMP. In mouse skin pieces maximum 
accumulation (about 6 times the basal level) occurred 
after 2 min incubation and was followed by a rapid 
decline in the cyclic AMP level. This "ischemic" rise in 
epidermal cyclic AMP was greatly reduced if skin was 
used 16 hr after a single application of 17 nmoles of TP A. 
The effect of TP A on cyclic AMP accumulation in re-
sponse to ischemia was first observed at 1 hr after TP A 
treatment and was maximal at 4 hr. The lack of "is-
chemic" response in TP A-treated skin was not related to 
an increase in the activity of cyclic AMP phosphodies-
terase after TP A application. In addition, the accumula-
tion of cyclic AMP in skin in response to both ischemia 
and exposure to isoproterenol, adenosine, histamine, or 
prostaglandin E2 (PGE2) was not observed in skin treated 
with the tumor promoter TP A. 
The basal level of adenosine 3',5'-monophosphate (cyclic 
AMP) increases markedly in several tissues [1-4) including pig 
[5] and mouse skin [6,7) after excision. This change in cyclic 
AMP level has been considered due to ischemia (cessation of 
blood flo~). Despite several efforts made to understand the 
molecular mechanism of this accumulation of cyclic AMP, the 
reason for its OCCUlTence remains unresolved. In a recent report 
[8] we have shown that the pulse in cyclic AMP levels is not 
due to the release of materials which activate adenylate cyclase 
after binding to cellular receptors. In addition, it was also shown 
thalthe functional interaction between the receptors for various 
stimulators and adenylate cyclase is maintained during the 
cyclic AMP accumulation in response to ischemia. 
Phorbol ester tumor promoters such as 12-0-tetradecanoyl-
phorbol-13-acetate (TPA) greatly depress the accumulation of 
cyclic AMP in mouse epidermis in response to f1-stimulation 
[7,9,10). It is believed that phorbol esters exert this effect by 
disrupting the coupling of adenylate cyclase molecules with the 
f1-adrenergic receptors [11). In the present study, we set out to 
understand the ischemic increase in cyclic AMP in mouse skin 
using TPA. 
MATERIALS AND METHODS 
Materials 
[8-3H]cyclic AMP (27.5 Ci/mmol) was obtained from the Radiochem· 
. ical Centre, Amersham, England. TP A was. purchased from Cambrian 
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cyclic AMP: cyclic adenosine 3' ,5' -monophosphate 
PGE2: prostaglandin E2 
TP A: 12-0-tetradecanoyl-phorbol-13-acetate 
Chemicals Ltd. , Cryodon, England. For this study. female Swiss albino 
mice (75-80 days old) were housed and treated with TPA (17 nmole; 
0.2 ml acetone) as described before [12]. 
Methods 
The procedure for the preparation of the skin pieces used to study 
changes in cyclic AMP levels in response to ischemia has been described 
previously [6]. Cyclic AMP determinations were done after column 
purification of the acid extracts from the skin [12]. Cyclic AMP phos-
phodiesterase activity was determined in epidermal extracts according 
to the method of Marks and Raab [13]. 
RESULTS 
Effect of TPA on Cyclic AMP Accumulation in Mouse Skin 
Pieces in Response to Ischemia 
The cyclic AMP levels were determined in excised skin pieces 
that were incubated in Bullough's medium [14] for various 
times at 37°C. A maximum 6-fold increase in cyclic AMP levels 
in acetone-treated skin pieces was observed at 2 min. The cyclic 
AMP levels started declining after 2 min and reached near basal 
level by 7 min. It was also shown that the "ischemic" rise in 
cyclic AMP was markedly decreased if skin was used 16 hI' after 
a single application of 17 nmol of TP A (see reference 6). The 
decline in cyclic AMP level in TPA-treated skin in response to 
ischemia started as early as 1 hr after TP A application and 
maximal effect on ischemic cyclic AMP accumulation was ob-
served by 4 hr (see Fig 1). Acetone itself had-slight effect on 
"ischemic" cyclic AMP accumulation at early 1-2 hr time 
points. However skin treated with acetone recovered by 3 hI' 
and showed a normal cyclic AMP response to ischemia. The 
zero time basal cyclic AMP levels in these experiments were 
obtained by collecting skin pieces into cold medium as de-
scribed previously [6). There was some indication of lower zero 
time basal cyclic AMP level in TPA-treated skin than acetone-
treated animals at later time points. However, we feel that 
these apparent differences are due to artifactual accumulation 
of cyclic AMP due to onset of ischemia in acetone- but not in 
TP A-treated skin pieces in the cold medium [8). 
Effect of TPA on Cyclic AMP Phosphodiesterase Activity in 
Adult Mouse Skin 
A simple mechanism to explain the lack of the "ischemic" 
accumulation of cyclic AMP in TP A-treated skin would be an 
increase in the activity of cyclic AMP phosphodiesterase after 
TP A treatment. As shown in Table I, no increase in the activity 
of this enzyme was observed in skin up to 4 hr after treatment. 
The low affinity enzyme activity increased nearly 3-fold over 
control between 4-8 hr after TP A application confIrming earlier 
fmding of Verma, Froscio, and MUlTay [15). 
Augmentation of Ischemic Cyclic AMP Accumulation in 
Skin Pieces by Isoproterenol, Adenosine, Histamine or PGE2 
264 
Several known stimulators of adenylate cyclase were tested 
for their effects on "ischemic" cyclic AMP levels. Fig 2 dem-
onstrates the augmentation of "ischemic" cyclic AMP levels in 
skin pieces incubated for 2 min with various concentrations of 
isoproterenol. Maximal enhancement of "ischemic" cyclic AMP 
was obtained at 10 tJ.M isoproterenol concentration. When this 
maximally active concentration of isoproterenol was added to 
the flask containing skin pieces, "ischemic" cyclic AMP accu-
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FIG 1. Effect of TPA on cyclic AMP accumulation in mouse skin 
pieces in response to ischemia. Mice were treated with acetone 01' 17 
nmol of TPA as described in Methods. At various times after treatment, 
animals were killed and the cyclic AMP determinations in acetone 
(0) or TPA-treated (e) skin pieces were done after a 2 min incubation 
at 37°C. The basal levels of cyclic AMP in acetone (6 ) and TPA-
treated (A) skin were determined as described previously (6). Each 
point is the mean ± SE of determinations caJ'l'ied out on 6 skin pieces 
from 3 animals. 
TABLE I. Effect of TPA on cyclic AMP phosphodiesterase activity 
in adult mouse epiderm is" 
T ime after 
applica tion (hr) 
2 
4 
8 
Cyclic AMP phosphodiesterase activity (p moles cyclic AMP/ 
min/ mg prolein) 
2 I'M 400 I'M 
Acetone TPA Acetone TPA 
19.91 ± 2.10 23.64 ± 2.01 380 ± 25 4 17 ± 26 
25.00 ± 1.80 24.36 ± 2.1 3 513 ± 40 586 ± 35 
44.90 ± 6.78 41.05 ± 4.20 523 ± 42 1500 ± 72 
U At various times after acetone (0.2 ml) 01' TPA (17 nmol/ mouse in 
0.2 ml acetone) treatment epidermal extracts were prepared and phos-
phodiesterase activity was measured at 2 P.M and 400 P.M cyclic AMP 
concentrations as described in Methods. Each value is the mean ± SE 
of determination done on 6 samples from 3 animals. 
m ulation in acetone-treated skin but not in TPA-treated skin 
was augmented by about 2.5 times. The enhanced cyclic AMP 
levels by incubation of adult mouse skin pieces for 2 min at 
37°C, were further elevated by the addition of optimally active 
concentrations of either adenosine, histamine 01' PGE2 [4,8]. All 
these compounds mentioned above did not induce 'ischemic' 
cyclic AMP levels in TPA-treated skin pieces (Table II). 
DISCUSSION 
The incubation of mouse skin pieces in Bullough's medium 
at 37°C causes a rapid accumulation of cyclic AMP in this 
tissue and maximal rise in cyclic AMP level was seen at 2 min 
after incubation. Mufson, Simsiman, and Boutwell [7] also 
reported similru' increase in cyclic AMP levels in mouse skin at 
1 min after excision by simply maintaining the tissue at room 
temperature. An identical phenomenon of cyclic AMP increase 
has also been observed in brain and h erut [4]. S uch a rapid and 
transient increase in cyclic AMP level has been considered due 
to ischemic response. The " ischemic" rise is not observed if skin 
is used 4-16 hr after a single application of the tumor promoter 
TP A (see Fig 1 and reference 6) . It sh ould also be noted that 
TPA does not cause any shift in the accumulation of cyclic 
AMP in response to isch emia [6]. An increase in th e activity of 
epidermal cyclic AMP phosphodiesterase is not likely to be a 
primary reason for the TP A effect. Thus, although TP A induces 
an increase in the activity of low affmity cyclic AMP phospho-
diesterase after 4-8 hr, th e effect of TP A on th e " ischemic" 
accumulation of cyclic AMP stru·ts within an hour and fully 
develops by 4 hr. 
Addition of either adenosin e, histamine, isoproterenol, or 
PGE2 -resulted in an additional cyclic AMP accumulation in 
acetone-treated skin pieces in response to ischemia suggesting 
that the functional relationship between the receptors for sev-
eral activators is maintained well during ischemic response. All 
these stimulators of cyclase were totally ineffective in enhancing 
cyclic AMP accumulation in TPA-treated skin. This observa-
tion indicates that both the ischemic and normal receptor-
cyclase mechanism were blocked in skin following TP A appli-
cation. If "ischemic" cyclic AMP accumulation is dissociated 
from the normal receptor-cyclase activation [8], th e mechanism 
by which TP A exerts its effect on " ischemic" cyclic AMP 
response may not be related to the property of TP A to induce 
defective coupling between cellular receptors and cyclase mol-
ecules [11], which results in a negative response of several 
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FI G 2. Agument'ation of "ischemic" cyclic AMP accululation by 
various concentrations of isoprot crcnol. C.vC' il t: AMP determinations 
were done after a 2 min il1 (' ubnt ion at 37°C with various concentrations 
of isoproterenol. Basal level of cyclic AMP (prior to 2 min incubation) 
was 0.09 ± 0.01 pmol/ Jlg DNA. Each point is the mean ± SE of 
det erminations canied out on 6 skin pieces from 3 animals. 
TABLE II. Stimulation of cyclic AMP accumulation by either 
a.denosin e, hist.a.mine, PGE~ or isoproterenol ill. incubated sllin 
pieces from TPA-treated adult mice" 
Treatment 
None 
Adenosine (0.5 mM) 
Histamine (0.2 111M) 
PGE2 (3 P.M) 
Isoproterenol (10 p.M) 
Cyclic AMP (p molesfl.tg DNA) 
Acetone TPA 
0.66 ± 0.11 
1.16 ± 0.17 
1.00 ± 0.09 
1.14 ± 0.21 
1.70 ± 0.21 
0.11 ± 0.01 
0.13 ± 0.02 
0.08 ± 0.01 
0.07 ± 0.01 
0.11 ± 0.02 
" Mice were treated with 0.2 ml acetone 0 1' TPA (17 nmol in 0.2 ml 
acetone/mouse). Afte r 17 hr, skin pieces from these mice were incu-
bated at 37°C for 2 min in the presence of various stimulators of 
adenylate cyclase. Each value is the mean ± SE of determinations 
carried out on 6 skin pieces from 3 animals. 
Basal levels of cyclic AMP in acetone and TP A treated skin pieces 
were 0.16 ± 0.01 and 0.10 ± 0.01 P mol/fIg DNA, respectively. 
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stimulators of adenylate cyclase. We feel that TPA can also 
trigger some mechanism which affects the total cyclase activity 
under either "ischemic," receptor-cyclase, or both controls. 
Finally, we propose that the "ischemic" cyclic AMP pulse is 
probably sensitive to the redox state changes of the cells. Such 
redox changes can be induced by TP A through the generation 
of free radicals [16-19] such as superoxide anion and hydroxyl 
radicals. A similar mechanism involving the redox state in the 
"ischemic" cyclic AMP accumulation in mouse skin has been 
proposed earlier [8). 
The authors wish to thank Dr. Tom Slaga, Oak Ridge National 
Laboratory, for his help in the preparation of this manuscript. 
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